Le cancer de la prostate est le cancer le plus fréquemment diagnostiqué chez les hommes canadiens et la troisième cause de décès relié au cancer. Lorsque diagnostiqué à un stade précoce de la maladie, le cancer de la prostate est traité de manière curative par chirurgie et radiothérapie. Par contre, les thérapies actuelles ne peuvent éradiquer la maladie lorsqu’elle progresse à des stades avancés. Ces thérapies, comme la chimiothérapie et l’hormonothérapie, demeurent donc palliatives. Il est primordial d’optimiser de nouvelles thérapies visant l’élimination des cellules cancéreuses chez les patients atteints des stades avancés de la maladie. Une de ces nouvelles options thérapeutiques est l’immunothérapie. L’immunothérapie du cancer a fait des progrès considérables durant les dernières années. Cependant, les avancements encourageants obtenus lors d’essais précliniques ne se sont pas encore traduits en des résultats cliniques significatifs. En ce qui concerne le cancer de la prostate, les résultats négligeables suivants des interventions immunothérapeutiques peuvent être causés par le fait que la plupart des études sur le microenvironnement immunologique furent effectuées chez des modèles animaux. De plus la majorité des études sur l’immunologie tumorale humaine furent effectuées chez des patients atteints d’autres cancers, tels que le mélanome, et non chez les patients atteints du cancer de la prostate. Donc, le but central de cette thèse de doctorat est d’étudier le microenvironnement immunologique chez les patients atteints du cancer de la prostate afin de mieux définir les impacts de la tumeur sur le développement de la réponse immunitaire antitumorale. Pour réaliser ce projet, nous avons établi deux principaux objectifs de travail : (i) la caractérisation précise des populations des cellules immunitaires infiltrant la tumeur primaire et les ganglions métastatiques chez les patients atteints du cancer de la prostate; (ii) l’identification et l’étude des mécanismes immunosuppressifs exprimés par les cellules cancéreuses de la prostate. Les résultats présentés dans cette thèse démontrent que la progression du cancer de la prostate est associée au développement d’un microenvironnement immunosuppressif qui, en partie, est régulé par la présence des androgènes. L’étude initiale avait comme but la caractérisation du microenvironnement immunologique des ganglions drainant la tumeur chez des patients du cancer de la prostate. Les résultats présentés dans le chapitre III nous a permis de démontrer que les ganglions métastatiques comportent des signes cellulaires et histopathologiques associés à une faible réactivité immunologique. Cette immunosuppression ganglionnaire semble dépendre de la présence des cellules métastatiques puisque des différences immunologiques notables existent entre les ganglions non-métastatiques et métastatiques chez un même patient. La progression du cancer de la prostate semble donc associée au développement d’une immunosuppression affectant les ganglions drainant la tumeur primaire. Par la suite, nous nous sommes intéressés à l’impact de la thérapie par déplétion des androgènes (TDA) sur le microenvironnement immunologique de la tumeur primaire. La TDA est associée à une augmentation marquée de l’inflammation prostatique. De plus, les protocoles d’immunothérapies pour le cancer de la prostate actuellement évalués en phase clinique sont dirigés aux patients hormonoréfractaires ayant subi et échoué la thérapie. Cependant, peu d’information existe sur la nature de l’infiltrat de cellules immunes chez les patients castrés. Il est donc essentiel de connaître la nature de cet infiltrat afin de savoir si celui-ci peut répondre de manière favorable à une intervention immunothérapeutique. Dans le chapitre IV, je présente les résultats sur l’abondance des cellules immunes infiltrant la tumeur primaire suivant la TDA. Chez les patients castrés, les densités de lymphocytes T CD3+ et CD8+ ainsi que des macrophages CD68+ sont plus importantes que chez les patients contrôles. Nous avons également observé une corrélation entre la densité de cellules NK et une diminution du risque de progression de la maladie (rechute biochimique). Inversement, une forte infiltration de macrophages est associée à un plus haut risque de progression. Conjointement, durant cette étude, nous avons développé une nouvelle approche informatisée permettant la standardisation de la quantification de l’infiltrat de cellules immunes dans les échantillons pathologiques. Cette approche facilitera la comparaison d’études indépendantes sur la densité de l’infiltrat immun. Ces résultats nous ont donc permis de confirmer que les effets pro-inflammatoires de la TDA chez les patients du cancer de la prostate ciblaient spécifiquement les lymphocytes T et les macrophages. L’hypothèse intéressante découlant de cette étude est que les androgènes pourraient réguler l’expression de mécanismes immunosuppressifs dans la tumeur primaire. Dans le chapitre V, nous avons donc étudié l’expression de mécanismes immunosuppressifs par les cellules cancéreuses du cancer de la prostate ainsi que leur régulation par les androgènes. Notre analyse démontre que les androgènes augmentent l’expression de molécules à propriétés immunosuppressives telles que l’arginase I et l’arginase II. Cette surexpression dépend de l’activité du récepteur aux androgènes. Chez les patients castrés, l’expression de l’arginase II était diminuée suggérant une régulation androgénique in vivo. Nous avons observé que l’arginase I et l’arginase II participent à la prolifération des cellules du cancer de la prostate ainsi qu’à leur potentiel immunosuppressif. Finalement, nous avons découvert que l’expression de l’interleukin-8 était aussi régulée par les androgènes. De plus, l’interleukin-8, indépendamment des androgènes, augmente l’expression de l’arginase II. Ces résultats confirment que les androgènes participent au développement d’une microenvironnement immunosuppressif dans le cancer de la prostate en régulant l’expression de l’arginase I, l’arginase II et l’interleukin-8. En conclusion, les résultats présentés dans cette thèse témoignent du caractère unique du microenvironnement immunologique chez les patients atteints du cancer de la prostate. Nos travaux ont également permis d’établir de nouvelles techniques basées sur des logiciels d’analyse d’image afin de mieux comprendre le dialogue entre la tumeur et le système immunitaire chez les patients. Approfondir les connaissances sur les mécanismes de régulation du microenvironnement immunologique chez les patients atteint du cancer de la prostate permettra d’optimiser des immunothérapies mieux adaptées à éradiquer cette maladie. / Prostate cancer is the most frequently diagnosed cancer in Canadian men and the third cause of cancer related death. When diagnosed at an early stage, prostate cancer can be effectively cured by surgery and radiotherapy. However, current therapies do not eradicate the advanced stages of the disease. Treatment of prostate cancer via chemotherapy or hormonotherapy remains palliative. It is thus essential to optimize novel therapies whose goal is to eliminate tumor cells in patients with advanced prostate cancer. One such approach is immunotherapy. Cancer immunotherapy has made important strides in recent years. The encouraging progress observed in pre-clinical trials has nonetheless not translated to significant results in the clinical setting. Concerning prostate cancer, the limited clinical efficacy of current immunotherapeutic protocols could be explained by the lack of studies directly evaluating the immunological microenvironment in prostate cancer patients and not in animal models or in patients afflicted by other malignancies, such as melanoma. Thus, the fundamental goal of this Ph.D. thesis is to study the immunological microenvironment in prostate cancer patients in order to better understand the impact of the tumor on the development of the anti-tumoral immune response. To realize this project, we established two main working objectives: (i) to precisely characterize the immune cell populations in tumor draining lymph nodes (LNs) and in the primary tumor of prostate cancer patients; (ii) to identify and to study the immunosuppressive pathways expressed by prostate cancer cells. The results detailed in this thesis demonstrate that prostate cancer progression is associated with the development of an immunosuppressive microenvironment, which is regulated, in part, by the presence of androgens. The initial study was based on the characterization of the immunological microenvironment of tumor draining LNs of prostate cancer patients. The results presented in chapter III allowed us to demonstrate that metastatic lymph nodes displayed cellular and histopathological evidence associated with a reduced immunological reactivity. This LN immunosuppression seemed to be dependant on the presence of metastatic cells as we noted significant immunological differences between non-metastatic and metastatic lymph nodes of the same patient. Prostate cancer progression was thus associated with the development of an immunosuppressive state, which affected tumor-draining lymph nodes. Next, we studied the impact of androgen deprivation therapy (ADT) on the immunological microenvironment of the primary tumor. Following ADT, there is a marked augmentation in intra-prostatic inflammation. Immunotherapeutic protocols currently evaluated in clinical trials are targeted at hormone refractory patients, which have received and failed ADT. However, very little information is available regarding the nature of the post-ADT immune infiltrate. Thus, it becomes essential to understand whether this post-ADT infiltrate could positively react to immunotherapy. In chapter IV, I present the results of the quantification of the immune cell abundance within the primary tumor. In patients who have received ADT prior to surgery, there was an elevated density of CD3+ and CD8+ T lymphocytes as well as CD68+ macrophages compared to control patients. We also observed an inverse correlation between the NK cell density and the risk of disease progression (biochemical recurrence). Conversely, an elevated macrophage infiltration was associated with a higher risk of progression. Furthermore, for this study, we developed a novel computerized approach allowing for the standardization of the quantification of immune cell infiltrate. This approach could facilitate the interpretation of results from independent studies on the density of immune cells within pathological specimens. This study confirmed that the pro-inflammatory impact of androgen deprivation therapy in prostate cancer patients target specifically the T lymphocyte and macrophage populations. The interesting hypothesis arising from this study was that androgens could positively regulate the expression of immunosuppressive pathways within the primary tumor. In chapter V, we evaluated the immunosuppressive mechanisms expressed by prostate cancer cells and regulated by androgens. Our analysis demonstrate that androgens increase the expression of molecules with immunosuppressive properties, such as arginase I and arginase II in an androgen receptor dependent manner. This androgen regulated expression of arginase II was also observed in prostate cancer patients treated by ATD. We observed that arginase I and arginase II participate in prostate cancer cell proliferation as well as in their immunosuppressive potential. Finally, we discovered that interleukin-8 expression was also regulated by androgens. Moreover, interleukin-8, independently of androgens, increased the expression of arginase II. Altogether, these results confirmed that androgens participate in the development of an immunosuppressive microenvironment in prostate cancer by regulating the expression of arginase I, arginase II and interlukin-8. In conclusion, the results presented in this thesis attest to the unique character of the immunological microenvironment in prostate cancer patients. Our work has also allowed to establish novel software-based analysis methods in order to better understand the dialogue between the tumor and the immune system. Further understanding of the regulatory pathways involved in the immunological microenvironment will allow for the optimization of immunotherapies better suited to eradicate prostate cancer.

As leishmanioses são antropozoonoses com amplo problema de saúde pública, que acometem aproximadamente 12 milhões de indivíduos em todo o mundo e causam cerca de 60 mil mortes por ano. No Brasil, a leishmaniose tegumentar (LT) apresenta coeficiente médio de detecção de 16 casos por 100 mil habitantes, onde em notificações no estado do Maranhão apresenta um dos maiores índices de incidência. Os fármacos utilizados atualmente apresentam eficácia limitada e algumas vezes significante toxicidade e efeitos adversos, sendo necessária a busca por novos tratamentos. Um dos meios para obtenção deste propósito é obter extratos vegetais que proporcionem a inativação da enzima arginase presente no parasito e responsável pela produção de poliaminas essenciais a sua sobrevivência. A escolha do material vegetal foi baseada através de práticas medicinais de populações onde a planta Stachytarpheta cayennensis é utilizada como analgésica, antiinflamatória e no tratamento de úlceras causadas por Leishmania. A planta foi coletada e feita a identificação botânica, e a droga foi utilizada para preparo de dois extratos por decocção e maceração em etanol 50%. Ambos foram fracionados com n-butanol e utilizados em testes de inibição da arginase. A fração butanólica do chá (BUF) foi a que apresentou menor número de constituintes. A análise do BUF por ressonância magnética nuclear indicou a presença de uma mistura de 7:3 de verbascosídeo/isoverbascosideo. Em seguida foi realizado o teste de inibição enzimática com a mesma fração e com os compostos estruturalmente relacionado com o verbascosídeo: ácido cafeico (IC50 = 1.5 µM), ácido clorogênico (IC50 = 3.4 µM), e ácido rosmarínico (IC50 = 1.5 µM). O teste de inibição na forma promastigota do parasito com a fração (BUF-CHÁ) em 72h de tratamento apresentou EC50 de 51 µg/mL. A partir dos resultados encontrados faz-se necessário mais experimentos com a planta, como a realização de ensaios com amastigotas de Leishmania e teste de toxicidade celular. Conclusão: S. cayennensis pode ser uma promissora fonte de novos fármacos para leishmaniose. / Stachytarpheta cayennensis is a plant traditionally used to treat tegumentary Leishmaniasis and as an anti-inflammatory. The aim of this study was to evaluate the mechanisms of action of extracts from S. cayennensis on the arginase enzyme of the trypanosome parasite Leishmania (Leishmania) amazonensis. S. cayennensis was collected in Formosa da Serra do Maranhão, Brazil. Crude water extract was fractionated with n-butanol and fractions were tested against arginase enzymes collected from L. (L.) amazonensis. The most potent arginase inhibitor fraction was then tested against L. (L.) amazonensis promastigotes in axenic culture. To verify arginase inhibition in L. (L.) amazonensis, promastigote cultures were supplemented with L-arginine (substrate) and L-ornithine, a product of hydrolysis of L-arginine by the arginase enzyme. Butanolic fraction (BUF) is a potent L. (L.) amazonensis arginase inhibitor (IC50 = 5 ± 1 µg/mL). BUF showed an IC50 of 51 µg/mL against L. (L.) amazonensis promastigotas. In addition, caffeic acid and two acids containing caffeoyl moiety were tested against arginase showing IC50 1.5-3.4 µM. The inhibition of arginase by BUF in the promastigote cultures was demonstrated by adding L-ornithine, which enhances parasite growth. In conclusion, verbascoside present in S. cayennensis extracts (BUF) target the arginase enzyme of L. (L.) amazonensis, resulting in the death of the parasites.

O intestino apresenta a maior área do corpo exposta ao ambiente, recebendo constantemente antígenos provenientes da alimentação e de microrganismos. A fim de manter a homeostase, evitando respostas inflamatórias desnecessárias e ao mesmo tempo respondendo apropriadamente à possíveis ameaças ao tecido, as células intestinas tem que ser capazes de perceber e responder apropriadamente a uma diversa gama de perturbações vindas do ambiente. Além do seu vasto sistema imune o intestino também abriga o maior número de neurônios fora do sistema nervoso central, os quais compõe o Sistema Nervoso Entérico (SNE). O SNE é composto por aproximadamente 100 milhões de neurônios que são capazes de regular autonomamente diversas funções fisiológicas do intestino e também de receber e enviar sinais para os sistemas nervoso autônomo simpático e parassimpático. Diversas evidências clínicas correlacionam inflamações intestinais com alterações no SNE, demonstrando a importância de se entender melhor as relações neuroimunes presentes no intestino. Os macrófagos são células essências da imunidade inata que residem tanto na área do intestino conhecida como lâmina própria como também na área conhecida como muscularis. Essas células fagocíticas desempenham um importante papel nas respostas antibacterianas e também na manutenção da homeostase do tecido, sendo capazes de adaptar rapidamente sua fisiologia em resposta aos sinais ambientais. Neste trabalho avaliamos a existência de uma comunicação bidirecional entre macrófagos e neurônios intestinais. Caracterizamos as duas populações de macrófagos presentes no intestino em homeostase e após um estimulo com SpiB um mutante de Salmonella, avaliando assim como estas células respondem à sinais de infecção provenientes do lúmen intestinal. Utilizando abordagens in vivo e in vitro, observamos que os macrófagos presentes na região da muscularis respondem rapidamente a uma possível infecção presente no lúmen regulando positivamente genes de proteção tecidual e reparo de danos, como Arg1 e Chi3l3. Nossos resultados indicam ainda que são os neurônios através da liberação de norepinefrina capaz de ativar os receptores β2 adrenérgicos presentes nos macrófagos intestinais que induzem a expressão dos genes relacionados com a proteção tecidual e reparo de danos. Observamos ainda que esta via induzida através da ativação dos receptores β2 adrenérgicos parece conferir também aos macrófagos um papel neuro-protetor em caso de danos teciduais. Em conjunto nossos resultados indicam a presença de uma comunicação neuroimune bidirecional entre os neurônios e macrófagos intestinais capaz de modular a resposta dos macrófagos a uma infecção entérica e de proteger os neurônios em caso de danos teciduais / The intestine is the largest area of the body exposed to the environment, which receives food and microbe antigens. In order to maintain homeostasis, avoiding unnecessary inflammation, and at the same time responding properly to potential treats to the tissue, intestinal cells must be able to sense and respond properly to this diverse set of environmental perturbations. In addition to a vast immune system, the intestine also harbors the largest collection of neurons outside the central nervous system, which constitute the enteric nervous system (ENS). The ENS is composed of approximately 100 million neurons that are capable of regulating the physiological functions of the gut autonomously and also receive input and send signals to the sympathetic and parasympathetic nervous system. Numerous clinical findings correlate gut inflammation with abnormalities in the ENS, revealing the importance of a better understanding of the neuro-immune interactions at this site. Macrophages comprise an essential innate immune cell residing both in the intestinal lamina propria and muscularis regions. These phagocytic cells play important roles in anti-microbial responses but also in tissue homeostasis, being able to quickly adapt their physiology in response to environmental cues. We evaluated the crosstalk between intestinal macrophages and surrounding enteric neurons, characterizing how these cells respond to possible infection in the intestinal lumen. Using in vivo and in vitro approaches, we found that macrophages in the intestinal muscularis quickly respond to a possible distal luminal infection, up regulating tissue-protective and wound repair genes, like Arg1 and Chi3l3. Also, our results indicate that the neurons trough norepinephrine release and subsequent activation of the β2 adrenergic receptor present on the intestinal macrophages are the ones up regulating tissue-protective and wound repair genes. We also observed that this pathway, trough the β2 adrenergic receptor activation seems to induce a neuro-protective role to these macrophages under tissue damage scenarios. All together our results indicate that a neuro-immune crosstalk between neurons and macrophages modulates macrophages response towards enteric infections and confers neuro-protection in case of tissue damage

O intestino apresenta a maior área do corpo exposta ao ambiente, recebendo constantemente antígenos provenientes da alimentação e de microrganismos. A fim de manter a homeostase, evitando respostas inflamatórias desnecessárias e ao mesmo tempo respondendo apropriadamente à possíveis ameaças ao tecido, as células intestinas tem que ser capazes de perceber e responder apropriadamente a uma diversa gama de perturbações vindas do ambiente. Além do seu vasto sistema imune o intestino também abriga o maior número de neurônios fora do sistema nervoso central, os quais compõe o Sistema Nervoso Entérico (SNE). O SNE é composto por aproximadamente 100 milhões de neurônios que são capazes de regular autonomamente diversas funções fisiológicas do intestino e também de receber e enviar sinais para os sistemas nervoso autônomo simpático e parassimpático. Diversas evidências clínicas correlacionam inflamações intestinais com alterações no SNE, demonstrando a importância de se entender melhor as relações neuroimunes presentes no intestino. Os macrófagos são células essências da imunidade inata que residem tanto na área do intestino conhecida como lâmina própria como também na área conhecida como muscularis. Essas células fagocíticas desempenham um importante papel nas respostas antibacterianas e também na manutenção da homeostase do tecido, sendo capazes de adaptar rapidamente sua fisiologia em resposta aos sinais ambientais. Neste trabalho avaliamos a existência de uma comunicação bidirecional entre macrófagos e neurônios intestinais. Caracterizamos as duas populações de macrófagos presentes no intestino em homeostase e após um estimulo com SpiB um mutante de Salmonella, avaliando assim como estas células respondem à sinais de infecção provenientes do lúmen intestinal. Utilizando abordagens in vivo e in vitro, observamos que os macrófagos presentes na região da muscularis respondem rapidamente a uma possível infecção presente no lúmen regulando positivamente genes de proteção tecidual e reparo de danos, como Arg1 e Chi3l3. Nossos resultados indicam ainda que são os neurônios através da liberação de norepinefrina capaz de ativar os receptores β2 adrenérgicos presentes nos macrófagos intestinais que induzem a expressão dos genes relacionados com a proteção tecidual e reparo de danos. Observamos ainda que esta via induzida através da ativação dos receptores β2 adrenérgicos parece conferir também aos macrófagos um papel neuro-protetor em caso de danos teciduais. Em conjunto nossos resultados indicam a presença de uma comunicação neuroimune bidirecional entre os neurônios e macrófagos intestinais capaz de modular a resposta dos macrófagos a uma infecção entérica e de proteger os neurônios em caso de danos teciduais / The intestine is the largest area of the body exposed to the environment, which receives food and microbe antigens. In order to maintain homeostasis, avoiding unnecessary inflammation, and at the same time responding properly to potential treats to the tissue, intestinal cells must be able to sense and respond properly to this diverse set of environmental perturbations. In addition to a vast immune system, the intestine also harbors the largest collection of neurons outside the central nervous system, which constitute the enteric nervous system (ENS). The ENS is composed of approximately 100 million neurons that are capable of regulating the physiological functions of the gut autonomously and also receive input and send signals to the sympathetic and parasympathetic nervous system. Numerous clinical findings correlate gut inflammation with abnormalities in the ENS, revealing the importance of a better understanding of the neuro-immune interactions at this site. Macrophages comprise an essential innate immune cell residing both in the intestinal lamina propria and muscularis regions. These phagocytic cells play important roles in anti-microbial responses but also in tissue homeostasis, being able to quickly adapt their physiology in response to environmental cues. We evaluated the crosstalk between intestinal macrophages and surrounding enteric neurons, characterizing how these cells respond to possible infection in the intestinal lumen. Using in vivo and in vitro approaches, we found that macrophages in the intestinal muscularis quickly respond to a possible distal luminal infection, up regulating tissue-protective and wound repair genes, like Arg1 and Chi3l3. Also, our results indicate that the neurons trough norepinephrine release and subsequent activation of the β2 adrenergic receptor present on the intestinal macrophages are the ones up regulating tissue-protective and wound repair genes. We also observed that this pathway, trough the β2 adrenergic receptor activation seems to induce a neuro-protective role to these macrophages under tissue damage scenarios. All together our results indicate that a neuro-immune crosstalk between neurons and macrophages modulates macrophages response towards enteric infections and confers neuro-protection in case of tissue damage

Submitted by Maria Aparecida (cidazen@gmail.com) on 2017-11-13T14:56:22Z No. of bitstreams: 1 Bruno de Paulo Ribeiro.pdf: 5961190 bytes, checksum: b316a82f1788938af665bf050e74095d (MD5) / Made available in DSpace on 2017-11-13T14:56:22Z (GMT). No. of bitstreams: 1 Bruno de Paulo Ribeiro.pdf: 5961190 bytes, checksum: b316a82f1788938af665bf050e74095d (MD5) Previous issue date: 2017-11-09 / CAPES, CNPq, FAPEMA / Mechanisms involved in severe P. vivax malaria remain unclear. In this study, we investigated the influence of different Circumsporozoite Protein (CSP) variants on circulating plasma cytokines, parasite load and enzymes as arginase, nitric oxide synthase (NOS2) and superoxide dismutase (SOD), variables that determine the malária outcome, in individuals infected with Plasmodium vivax from a pre-Amazon area from Brazil. Samples of 25 patients infected exclusively with P. vivax and 9 healthy controls were collected and processed to obtain plasma, erythrocytes and mononuclear cells (PBMCs). Acute infection increases IL-6 and IL-10 and reduction TGF- compared to healthy controls. Only 8 patients had detectable concentrations of IFN-γ and IL-2, IL-4, TNF-, and IL-17 cytokines showed very low or undetectable concentrations in both groups. The activities of arginase and SOD were similarly increased in patients, whereas NOS2 activity, assessed indirectly by nitrite production, was unchanged relative to healthy subjects. CSP polymorphisms showed influence on the results. In addition to inducing the highest parasite loads in relation to VK210, VK247 variant also had higher concentrations of IL-6. Although IL-6 and IL-10 has been correlated in plasma, this correlation was only maintained in individuals infected with VK210. VK210 has also been shown to be related to the arginase activity increase, which may be related to the IL-10 increase induced by this variant. Polymorphisms of CSP and parasite load did not influence SOD activity. The systemic influence of the parasite was determinant for the observed profiles since all parameters of the host immune response that were altered in plasma returned to normal levels in the 48 h PBMCs culture supernatant. Finally, although increased in the patients, the production of IL- 10 followed against TGF- levels. This, associated to the increased levels of arginase, indicate that IL-10 may be produced by an alternative source in malaria. Thus, we propose that regulatory macrophages have an important role in the acute phase of vivax malaria and that CSP polymorphisms directly affect the control of the inflamed response and, consequently, the infection outcome. / Os mecanismos envolvidos na gravidade da malária causada por P. vivax ainda não foram completamente esclarecidos. Neste estudo foi avaliada a influência das diferentes variantes da Proteína Circunsporozoíta (CSP) sobre os níveis de citocinas plasmáticas, da carga parasitária e das enzimas arginase, óxido nítrico sintase (NOS2) e superóxido dismutase (SOD), variáveis que influenciam diretamente o desfecho da infecção, utilizando indivíduos infectados com Plasmodium vivax provenientes de uma área da pré-Amazônia brasileira. Amostras de 25 pacientes infectados exclusivamente por P. vivax e 9 controles saudáveis foram coletadas e processadas para obtenção do plasma, dos eritrócitos e das células mononucleares (PBMCs). A infecção aguda induziu aumentos nos níveis de IL-6 e IL-10 e redução nos níveis de TGF- em relação aos controles saudáveis. Apenas 8 pacientes tiveram concentrações detectáveis de IFN-  e as citocinas IL-2, IL-4, TNF- e IL-17 apresentaram concentrações muito baixas ou indetectáveis em ambos os grupos. As atividades de arginase e SOD estavam igualmente aumentadas, ao passo que a atividade de NOS2, avaliada indiretamente pela produção de nitritos, estava inalterada em relação aos indivíduos saudáveis. Os polimorfismos da CSP influenciaram diretamente os resultados obtidos. Além de induzir as maiores cargas parasitárias em relação à VK210, a variante VK247 também apresentou as maiores concentrações de IL-6. Apesar de IL-6 e IL-10 terem apresentado níveis correlacionados no plasma, esta correlação só se manteve nos indivíduos infectados com VK210, variante que também induziu aumento na atividade de arginase. Os polimorfismos da CSP e a carga parasitária não apresentaram correlação com as atividades da SOD e da NOS2. Ratificando que a influência sistêmica do parasito foi determinante para os perfis observados, todos os parâmetros da resposta imune do hospedeiro que estavam alterados no plasma voltaram a patamares normais no sobrenadante de cultura de 48 h das PBMCs. Por fim, apesar de aumentada nos pacientes, a produção de IL-10 não foi acompanhada pela produção de TGF-. Isto, associado aos níveis aumentados de arginase observados, indicam que a IL-10 pode estar sendo produzida por uma fonte alternativa na malária. Desta forma, propomos que macrófagos reguladores têm importante participação na fase aguda da malária vivax e que os polimorfismos da CSP afetam diretamente o controle da resposta inflamatória e, consequentemente, o desfecho da infecção.

Le cancer de la prostate est le cancer le plus fréquemment diagnostiqué chez les hommes canadiens et la troisième cause de décès relié au cancer. Lorsque diagnostiqué à un stade précoce de la maladie, le cancer de la prostate est traité de manière curative par chirurgie et radiothérapie. Par contre, les thérapies actuelles ne peuvent éradiquer la maladie lorsqu’elle progresse à des stades avancés. Ces thérapies, comme la chimiothérapie et l’hormonothérapie, demeurent donc palliatives. Il est primordial d’optimiser de nouvelles thérapies visant l’élimination des cellules cancéreuses chez les patients atteints des stades avancés de la maladie. Une de ces nouvelles options thérapeutiques est l’immunothérapie. L’immunothérapie du cancer a fait des progrès considérables durant les dernières années. Cependant, les avancements encourageants obtenus lors d’essais précliniques ne se sont pas encore traduits en des résultats cliniques significatifs. En ce qui concerne le cancer de la prostate, les résultats négligeables suivants des interventions immunothérapeutiques peuvent être causés par le fait que la plupart des études sur le microenvironnement immunologique furent effectuées chez des modèles animaux. De plus la majorité des études sur l’immunologie tumorale humaine furent effectuées chez des patients atteints d’autres cancers, tels que le mélanome, et non chez les patients atteints du cancer de la prostate. Donc, le but central de cette thèse de doctorat est d’étudier le microenvironnement immunologique chez les patients atteints du cancer de la prostate afin de mieux définir les impacts de la tumeur sur le développement de la réponse immunitaire antitumorale. Pour réaliser ce projet, nous avons établi deux principaux objectifs de travail : (i) la caractérisation précise des populations des cellules immunitaires infiltrant la tumeur primaire et les ganglions métastatiques chez les patients atteints du cancer de la prostate; (ii) l’identification et l’étude des mécanismes immunosuppressifs exprimés par les cellules cancéreuses de la prostate. Les résultats présentés dans cette thèse démontrent que la progression du cancer de la prostate est associée au développement d’un microenvironnement immunosuppressif qui, en partie, est régulé par la présence des androgènes. L’étude initiale avait comme but la caractérisation du microenvironnement immunologique des ganglions drainant la tumeur chez des patients du cancer de la prostate. Les résultats présentés dans le chapitre III nous a permis de démontrer que les ganglions métastatiques comportent des signes cellulaires et histopathologiques associés à une faible réactivité immunologique. Cette immunosuppression ganglionnaire semble dépendre de la présence des cellules métastatiques puisque des différences immunologiques notables existent entre les ganglions non-métastatiques et métastatiques chez un même patient. La progression du cancer de la prostate semble donc associée au développement d’une immunosuppression affectant les ganglions drainant la tumeur primaire. Par la suite, nous nous sommes intéressés à l’impact de la thérapie par déplétion des androgènes (TDA) sur le microenvironnement immunologique de la tumeur primaire. La TDA est associée à une augmentation marquée de l’inflammation prostatique. De plus, les protocoles d’immunothérapies pour le cancer de la prostate actuellement évalués en phase clinique sont dirigés aux patients hormonoréfractaires ayant subi et échoué la thérapie. Cependant, peu d’information existe sur la nature de l’infiltrat de cellules immunes chez les patients castrés. Il est donc essentiel de connaître la nature de cet infiltrat afin de savoir si celui-ci peut répondre de manière favorable à une intervention immunothérapeutique. Dans le chapitre IV, je présente les résultats sur l’abondance des cellules immunes infiltrant la tumeur primaire suivant la TDA. Chez les patients castrés, les densités de lymphocytes T CD3+ et CD8+ ainsi que des macrophages CD68+ sont plus importantes que chez les patients contrôles. Nous avons également observé une corrélation entre la densité de cellules NK et une diminution du risque de progression de la maladie (rechute biochimique). Inversement, une forte infiltration de macrophages est associée à un plus haut risque de progression. Conjointement, durant cette étude, nous avons développé une nouvelle approche informatisée permettant la standardisation de la quantification de l’infiltrat de cellules immunes dans les échantillons pathologiques. Cette approche facilitera la comparaison d’études indépendantes sur la densité de l’infiltrat immun. Ces résultats nous ont donc permis de confirmer que les effets pro-inflammatoires de la TDA chez les patients du cancer de la prostate ciblaient spécifiquement les lymphocytes T et les macrophages. L’hypothèse intéressante découlant de cette étude est que les androgènes pourraient réguler l’expression de mécanismes immunosuppressifs dans la tumeur primaire. Dans le chapitre V, nous avons donc étudié l’expression de mécanismes immunosuppressifs par les cellules cancéreuses du cancer de la prostate ainsi que leur régulation par les androgènes. Notre analyse démontre que les androgènes augmentent l’expression de molécules à propriétés immunosuppressives telles que l’arginase I et l’arginase II. Cette surexpression dépend de l’activité du récepteur aux androgènes. Chez les patients castrés, l’expression de l’arginase II était diminuée suggérant une régulation androgénique in vivo. Nous avons observé que l’arginase I et l’arginase II participent à la prolifération des cellules du cancer de la prostate ainsi qu’à leur potentiel immunosuppressif. Finalement, nous avons découvert que l’expression de l’interleukin-8 était aussi régulée par les androgènes. De plus, l’interleukin-8, indépendamment des androgènes, augmente l’expression de l’arginase II. Ces résultats confirment que les androgènes participent au développement d’une microenvironnement immunosuppressif dans le cancer de la prostate en régulant l’expression de l’arginase I, l’arginase II et l’interleukin-8. En conclusion, les résultats présentés dans cette thèse témoignent du caractère unique du microenvironnement immunologique chez les patients atteints du cancer de la prostate. Nos travaux ont également permis d’établir de nouvelles techniques basées sur des logiciels d’analyse d’image afin de mieux comprendre le dialogue entre la tumeur et le système immunitaire chez les patients. Approfondir les connaissances sur les mécanismes de régulation du microenvironnement immunologique chez les patients atteint du cancer de la prostate permettra d’optimiser des immunothérapies mieux adaptées à éradiquer cette maladie. / Prostate cancer is the most frequently diagnosed cancer in Canadian men and the third cause of cancer related death. When diagnosed at an early stage, prostate cancer can be effectively cured by surgery and radiotherapy. However, current therapies do not eradicate the advanced stages of the disease. Treatment of prostate cancer via chemotherapy or hormonotherapy remains palliative. It is thus essential to optimize novel therapies whose goal is to eliminate tumor cells in patients with advanced prostate cancer. One such approach is immunotherapy. Cancer immunotherapy has made important strides in recent years. The encouraging progress observed in pre-clinical trials has nonetheless not translated to significant results in the clinical setting. Concerning prostate cancer, the limited clinical efficacy of current immunotherapeutic protocols could be explained by the lack of studies directly evaluating the immunological microenvironment in prostate cancer patients and not in animal models or in patients afflicted by other malignancies, such as melanoma. Thus, the fundamental goal of this Ph.D. thesis is to study the immunological microenvironment in prostate cancer patients in order to better understand the impact of the tumor on the development of the anti-tumoral immune response. To realize this project, we established two main working objectives: (i) to precisely characterize the immune cell populations in tumor draining lymph nodes (LNs) and in the primary tumor of prostate cancer patients; (ii) to identify and to study the immunosuppressive pathways expressed by prostate cancer cells. The results detailed in this thesis demonstrate that prostate cancer progression is associated with the development of an immunosuppressive microenvironment, which is regulated, in part, by the presence of androgens. The initial study was based on the characterization of the immunological microenvironment of tumor draining LNs of prostate cancer patients. The results presented in chapter III allowed us to demonstrate that metastatic lymph nodes displayed cellular and histopathological evidence associated with a reduced immunological reactivity. This LN immunosuppression seemed to be dependant on the presence of metastatic cells as we noted significant immunological differences between non-metastatic and metastatic lymph nodes of the same patient. Prostate cancer progression was thus associated with the development of an immunosuppressive state, which affected tumor-draining lymph nodes. Next, we studied the impact of androgen deprivation therapy (ADT) on the immunological microenvironment of the primary tumor. Following ADT, there is a marked augmentation in intra-prostatic inflammation. Immunotherapeutic protocols currently evaluated in clinical trials are targeted at hormone refractory patients, which have received and failed ADT. However, very little information is available regarding the nature of the post-ADT immune infiltrate. Thus, it becomes essential to understand whether this post-ADT infiltrate could positively react to immunotherapy. In chapter IV, I present the results of the quantification of the immune cell abundance within the primary tumor. In patients who have received ADT prior to surgery, there was an elevated density of CD3+ and CD8+ T lymphocytes as well as CD68+ macrophages compared to control patients. We also observed an inverse correlation between the NK cell density and the risk of disease progression (biochemical recurrence). Conversely, an elevated macrophage infiltration was associated with a higher risk of progression. Furthermore, for this study, we developed a novel computerized approach allowing for the standardization of the quantification of immune cell infiltrate. This approach could facilitate the interpretation of results from independent studies on the density of immune cells within pathological specimens. This study confirmed that the pro-inflammatory impact of androgen deprivation therapy in prostate cancer patients target specifically the T lymphocyte and macrophage populations. The interesting hypothesis arising from this study was that androgens could positively regulate the expression of immunosuppressive pathways within the primary tumor. In chapter V, we evaluated the immunosuppressive mechanisms expressed by prostate cancer cells and regulated by androgens. Our analysis demonstrate that androgens increase the expression of molecules with immunosuppressive properties, such as arginase I and arginase II in an androgen receptor dependent manner. This androgen regulated expression of arginase II was also observed in prostate cancer patients treated by ATD. We observed that arginase I and arginase II participate in prostate cancer cell proliferation as well as in their immunosuppressive potential. Finally, we discovered that interleukin-8 expression was also regulated by androgens. Moreover, interleukin-8, independently of androgens, increased the expression of arginase II. Altogether, these results confirmed that androgens participate in the development of an immunosuppressive microenvironment in prostate cancer by regulating the expression of arginase I, arginase II and interlukin-8. In conclusion, the results presented in this thesis attest to the unique character of the immunological microenvironment in prostate cancer patients. Our work has also allowed to establish novel software-based analysis methods in order to better understand the dialogue between the tumor and the immune system. Further understanding of the regulatory pathways involved in the immunological microenvironment will allow for the optimization of immunotherapies better suited to eradicate prostate cancer.

Submitted by Ana Maria Fiscina Sampaio (fiscina@bahia.fiocruz.br) on 2013-11-06T14:31:55Z No. of bitstreams: 1 Jaqueline Franca Costa Aspectos imunopatogênicos da leishmaniose cutanêa...pdf: 1509776 bytes, checksum: 2d3824cc711f84d908e61378ac3d4a8c (MD5) / Made available in DSpace on 2013-11-06T14:31:55Z (GMT). No. of bitstreams: 1 Jaqueline Franca Costa Aspectos imunopatogênicos da leishmaniose cutanêa...pdf: 1509776 bytes, checksum: 2d3824cc711f84d908e61378ac3d4a8c (MD5) Previous issue date: 2013 / Universidade Federal da Bahia. Faculdade de Medicina da Bahia. Salvador, BA, Brasil / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / A progressão crônica da LCD é atribuída à falta da imunidade mediada por células específica para antígeno de Leishmania e predominância de uma resposta do tipo Th2. Neste sentido, tanto fatores do parasita quanto do hospedeiro podem atuar na desativação da resposta imune favorecendo a replicação da Leishmania. Inicialmente avaliamos o papel da exposição de fosfatidilserina na infecção de macrófagos murinos com Leishmania amazonensis isolados de pacientes com LCD. Para isso, macrófagos peritoneais de camundongos F1(BALB/c x C57BL/6) foram infectados com os diferentes isolados obtidos de pacientes com LCD e LCL. Os isolados obtidos de pacientes com LCD apresentaram maior expressão de PS do que os isolados de pacientes com LCL após 24 horas de infecção. Em seguida, avaliamos a infectividade dos diferentes isolados. As amastigotas de pacientes com LCD apresentaram maior porcentagem de macrófagos infectados e índice de infecção, quando comparados com amastigotas de pacientes com LCL. Quanto ao mecanismo, o grupo infectado com os isolados de pacientes com LCD apresentou um aumento na relação TGF-β/TNF-α e IL-10/TNF-α em relação ao grupo LCL. A análise de correlação revelou que a porcentagem de macrófagos infectados, o índice de infecção, os índices de TGF-β/TNF-α e IL-10/TNF-α, bem como o tamanho dos vacúolos estão diretamente associados a maior exposição de PS. Além disso, o número de lesões e o tempo de doença dos pacientes com LCD também estão associados á exposição de PS. O reconhecimento de PS tem como consequência a produção de TGF, IL-10, IL-4 e PGE2, que ativam a via da enzima arginase e consequentemente a produção de poliaminas. Por isso buscamos investigar a participação de tais mediadores em pacientes com LCD. Os níveis da arginase I, ODC e TGF-β no plasma de pacientes com LCD estava elevados quando comparado com os pacientes com LCL ou o controle saudável da área endêmica. Por outro lado, os níveis de TNF-α, IL-12, MCP-1 e CXCL-10 estavam reduzidos no plasma de pacientes com LCD comparado aos pacientes com LCL. Os níveis de arginase apresentaram correlação positiva com ODC, TGF-β e PGE e correlação negativa com TNF-α, IL-12, MCP-1 e CXCL-10. A produção da arginase e ODC também foi avaliada nas lesões dos pacientes através de imunohistoquímica. As lesões dos pacientes com LCD apresentaram uma marcação mais intensa e difusa do que as de LCL. Além disso, a expressão da cicloxigenase 2 também estava aumentada nas lesões de LCD. A expressão do mRNA das enzimas fosfolipase A2, COX-2, prostaglandina sintase, espermina e espermidina sintase apresentaram uma relação positiva com a enzima arginase, indicando que esta interfere diretamente no metabolismo dos mediadores lipídicos e na via de síntese das poliaminas. A inibição das enzimas arginase e ODC com nor-NOHA e DFMO, respectivamente, reduziu a carga parasitária de macrófagos humanos infectados com L. amazonensis após 72 h de infecção. Além disso, os inibidores reduziram a produção de TGF e PGE2 no sobrenadante das culturas. Em conjunto, nossos dados sugerem que a liberação local e sistêmica de prostaglandinas e poliaminas associadas à via da arginase em pacientes com LCD deve estar associada com a inabilidade em montar uma resposta imune eficiente contra a infecção por Leishmania proporcionando um ambiente favorável para a replicação do parasita e disseminação da doença. Nossos resultados mostram também que este ambiente imunossuprimido pode ser induzido pela exposição de PS na superfície de L. amazonensis deflagrando uma resposta anti-inflamatória nos pacientes com LCD. / The chronic progression of DCL is attributed to the lack of specific cell-mediated immunity to Leishmania antigen and predominance of a Th2-type response. In this sense, both factors of the parasite and the host can act in the deactivation of immune response, favoring parasite replication. Initially we evaluate the role of phosphatidylserine exposure in murine macrophages infected with L. amazonensis isolated from patients with DCL. First, peritoneal macrophages of mice F1 (BALB/c x C57BL/6) were infected with different isolates from patients with DCL and LCL. The DCL isolates showed higher PS expression than the LCL isolates after 24 hours of infection.. The DCL-amastigotes patients showed a higher percentage of infected macrophages and the infectivity index when compared with patients with LCL- amastigotes. Regarding the mechanism, the group infected with isolates from patients with LCD showed an increase in TGF/TNF and IL-10/TNF when compared with LCL group. Correlation analysis revealed that the percentage of infected macrophages, the infectivity index, the rate of TGF/TNF and IL-10/TNF as well as the size of the vacuoles are directly associated with higher PS exposure. Moreover, the number of lesions and disease duration of DCL patients are also associated with PS exposure. Recognition of PS results in the production of TGF, IL-10, IL-4 and PGE2, molecules with anti-inflammatory role that activate the enzyme arginase and consequently the polyamines production. Therefore, we investigated the involvement of these mediators in patients with DCL. The plasma of DCL patients showed high levels of arginase, ODC and TGF compared to the LCL patients or healthy control from endemic area. On the other hand, the levels of TNF, IL-12, MCP-1 and CXCL-10 were reduced in the DCL patients plasma compared to patients with LCL. Arginase levels were positively correlated with ODC, TGF and PGE and negatively correlated with TNF, IL-12, MCP-1 and CXCL-10. The production of arginase and ODC was also evaluated in the lesions of patients by immunohistochemistry. The DCL lesions showed a more intense and diffuse staining than LCL lesions. Furthermore, the expression of cyclooxygenase-2 was also increased in lesions of DCL. The mRNA expression of the enzymes phospholipase A2, COX-2, prostaglandin synthase, spermine synthase and spermidine synthase showed a positive relationship with the arginase enzyme, indicating that it directly interferes with the metabolism of lipid mediators and in synthesis of polyamines. The inhibition of the enzyme arginase and ODC with nor-NOHA and DFMO, respectively, reduced the parasite load of L. amazonensis human infected macrophages 72 h after infection. Moreover, NOHA and DFMO reduced TGF and PGE2 production in the supernatant of cultures. Together, local and systemic release of prostaglandins, arginase and polyamines pathways in DCL should be associated with the inability of these patients to mount effective immune response against infection by Leishmania providing a favorable environment for replication and spread of the parasite disease. Our results also show that this immunosuppressed environment can be induced by PS exposure on the L. amazonensis surface triggering anti-inflammatory response in DCL patients.

Les patients atteints de polyarthrite rhumatoide (PR) ont une diminution de l'espérance de vie de 10 à 15 ans. Cette augmentation de la mortalité semble liée à un processus athéromateux accéléré. La dysfonction endothéliale (DE) joue un rôle clé dans ce processus. L'arginase est une enzyme qui régule le niveau de NO par compétition avec la NO Synthase (NOS) pour leur substrat commun, la L-arginine.Nous avons montré que la vasodilatation Acétylcholine (ACh) dépendante était altérée dans le modèle d'Arthrite Induite à Adjuvant (AIA) chez le rat Lewis, témoignant d'une DE. L'incubation des anneaux aortiques avec la nor-NOHA un inhibiteur sélectif d'arginase a amélioré la réponse vasculaire à l'ACh chez les rats AIA. L'activité et l'expression vasculaire de l'arginase se sont révélées augmentées chez les rats AIA et corrélées positivement à la sévérité de l'arthrite.Nous avons caractérisé les mécanismes impliqués dans la DE du rat AIA. Nos résultats ont montré que la DE mettait enjeu une diminution de l'activité de la NO synthase, un déficit en EDHF, une suractivité de la COX-2, ainsi qu'une production excessive des anions superoxydes. Le traitement curatif des rats AIA par la nor-NOHA pendant 3 semaines, a permis de restaurer la fonction endothéliale. L'inhibition de l'arginase n'a pas modifié l'atteinte articulaire des rats AIA.Nos travaux ont permis de mieux comprendre la physiopathologie de la DE associée à la PR et ont déterminé pour la première fois le rôle délétère de l'arginase dans cette anomalie. Ils ouvrent des perspectives quant à l'utilisation des inhibiteurs d'arginase comme futurs traitements pharmacologiques de l'atteinte vasculaire du patient PR / Patients with RA are characterized by a decrease in life expectancy of 10 to 15 years. This increase in mortality seems to be related to an accelerated atheroma process. Endothelial dysfunction (ED) has a key role in these processes. The arginase is an enzyme which regulates the level of NO by competing with the NO synthase (NOS) to their common substrate, L-arginine.We showed that acetylcholine (ACh) dependent vasodilation was altered in the model of Adjuvant Induced Arthritis (AIA) in Lewis rats, indicating a endothelial dysfunction. The incubation of aortic rings with nor-NOHA has improved the vascular response to ACh in AIA rats. The activity and expression of vascular arginase are increased in AIA rats and positively correlated with the severity of arthritis.We characterized the mechanisms involved in DE in AIA rats. Our results showed that ED involved a decrease of activity of NO synthase, a decrease of EDHF, overactiviry of COX-2, thromboxane synthase and prostacyclin synthase, as well as excessive superoxide anions. The cure of AIA rats by a selective inhibitor of arginase, nor-NOHA for 3 weeks, has restored endothelial function. In contrast, inhibition of arginase activity did not change the weight, the diameter of ankles, radiological or histological articular damage in AIA rats.Our work has led to a better understanding of pathophysiology of ED associated with rheumatoid arthritis and determined for the first time the deleterious role of arginase in this vascular anomaly. These results open prospects for the use of arginase inhibitors as future pharmacological treatment of vascular patient PR.

Le travail de la thèse présente une série de (bio)capteurs conductimétriques, à base de la clinoptilolite, pour la détermination de l’ammonium, de l’urée et de la L-arginine. La clinoptilolite, le matériau nanométrique, possédant des propriétés de la sorption intrinsèque et une capacité d’échange cationique vis-à-vis des espèces ammonium, a été d’abord utilisée pour la réalisation d’un microcapteur conductimétrique sélectif à NH4+. Ci-après, une application de ce nanomatériau dans les biocapteurs est favorable pour le fonctionnement dans les solutions tampons multicomposants. Parmi plusieurs variantes de biocapteurs à l’urée à base de la zéolite, la plus intéressante est le biocapteur, dans lequel la couche de la clinoptilolite, déposée sur le transducteur, a été recouverte par le dépôt de la couche de l’uréase et de la zéolite. Pour l’élaboration d’un biocapteur conductimétrique hautement sensible pour la détermination de la L-arginine, l’arginase et l’uréase ont été co-réticulées sur le transducteur. Une détermination quantitative de la L-arginine dans une solution buvable « Arginine Veyron » a montré un fort accord avec les données fournies par le producteur. Une procédure détaillée de l’optimisation du biocapteur conductimétrique pour la détection de la L-arginine dans le sérum bovin a été proposée. La clinoptilolite a été également appliquée comme un modificateur dans la co-immobilisation de l’arginase et l’uréase pour améliorer les caractéristiques analytiques de biocapteur conductimétriques pour la détermination de la L-arginine / Currentwork presents a serie of conductometric (bio)sensors based on clinoptilolite, for ammonium, urea and L-arginine determination. Clinoptilolite, a nanoscale material possessing exceptional sorption and cation-exchange properties toward ammonium species, was initially used for the development of NH4+-selective conductometric microsensor. The clinoptilolite-based microsensor was selective toward ammonium in the presence of interferences that are commonly found along with ammonium in natural waters. Hereafter, an application of this nanomaterial in biosensors is favorable for operation in multicomponent buffer solutions. Among the several variants of the urea biosensors based on zeolite, considerably better characteristics were obtained for the biosensor comprising a clinoptilolite adlayer and an upper layer of immobilized urease and zeolite. In the work, for first time was developed a highly sensitive conductometric biosensor for L-arginine determination based on arginase and urease co-immobilized in a single membrane. The results of a quantitative determination of L-arginine in a drinkable solution “Arginine Veyron”, obtained by the biosensor, were in high correlation with the data provided by the producer. The L-arginine conductometric biosensor was optimized for the serum analysis. Clinoptilolite was also applied as a modifier in co-immobilization of arginase and urease for the improvement of analytical characteristics of the conductometric biosensor for L-arginine determination

As leishmanioses são antropozoonoses com amplo problema de saúde pública, que acometem aproximadamente 12 milhões de indivíduos em todo o mundo e causam cerca de 60 mil mortes por ano. No Brasil, a leishmaniose tegumentar (LT) apresenta coeficiente médio de detecção de 16 casos por 100 mil habitantes, onde em notificações no estado do Maranhão apresenta um dos maiores índices de incidência. Os fármacos utilizados atualmente apresentam eficácia limitada e algumas vezes significante toxicidade e efeitos adversos, sendo necessária a busca por novos tratamentos. Um dos meios para obtenção deste propósito é obter extratos vegetais que proporcionem a inativação da enzima arginase presente no parasito e responsável pela produção de poliaminas essenciais a sua sobrevivência. A escolha do material vegetal foi baseada através de práticas medicinais de populações onde a planta Stachytarpheta cayennensis é utilizada como analgésica, antiinflamatória e no tratamento de úlceras causadas por Leishmania. A planta foi coletada e feita a identificação botânica, e a droga foi utilizada para preparo de dois extratos por decocção e maceração em etanol 50%. Ambos foram fracionados com n-butanol e utilizados em testes de inibição da arginase. A fração butanólica do chá (BUF) foi a que apresentou menor número de constituintes. A análise do BUF por ressonância magnética nuclear indicou a presença de uma mistura de 7:3 de verbascosídeo/isoverbascosideo. Em seguida foi realizado o teste de inibição enzimática com a mesma fração e com os compostos estruturalmente relacionado com o verbascosídeo: ácido cafeico (IC50 = 1.5 µM), ácido clorogênico (IC50 = 3.4 µM), e ácido rosmarínico (IC50 = 1.5 µM). O teste de inibição na forma promastigota do parasito com a fração (BUF-CHÁ) em 72h de tratamento apresentou EC50 de 51 µg/mL. A partir dos resultados encontrados faz-se necessário mais experimentos com a planta, como a realização de ensaios com amastigotas de Leishmania e teste de toxicidade celular. Conclusão: S. cayennensis pode ser uma promissora fonte de novos fármacos para leishmaniose. / Stachytarpheta cayennensis is a plant traditionally used to treat tegumentary Leishmaniasis and as an anti-inflammatory. The aim of this study was to evaluate the mechanisms of action of extracts from S. cayennensis on the arginase enzyme of the trypanosome parasite Leishmania (Leishmania) amazonensis. S. cayennensis was collected in Formosa da Serra do Maranhão, Brazil. Crude water extract was fractionated with n-butanol and fractions were tested against arginase enzymes collected from L. (L.) amazonensis. The most potent arginase inhibitor fraction was then tested against L. (L.) amazonensis promastigotes in axenic culture. To verify arginase inhibition in L. (L.) amazonensis, promastigote cultures were supplemented with L-arginine (substrate) and L-ornithine, a product of hydrolysis of L-arginine by the arginase enzyme. Butanolic fraction (BUF) is a potent L. (L.) amazonensis arginase inhibitor (IC50 = 5 ± 1 µg/mL). BUF showed an IC50 of 51 µg/mL against L. (L.) amazonensis promastigotas. In addition, caffeic acid and two acids containing caffeoyl moiety were tested against arginase showing IC50 1.5-3.4 µM. The inhibition of arginase by BUF in the promastigote cultures was demonstrated by adding L-ornithine, which enhances parasite growth. In conclusion, verbascoside present in S. cayennensis extracts (BUF) target the arginase enzyme of L. (L.) amazonensis, resulting in the death of the parasites.